OR

Orlaith Ryan

Chief Technical Officer

Shorla Pharma


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Shorla Pharma
Industry
pharmaceuticals
Employees
43.0
Seniority
C suite
Total Funding
43300000.0
Latest Funding
Series B

Technologies

Salesforce TurboSMTP Outlook Microsoft Office 365 Apache reCAPTCHA WordPress.org Nginx Vimeo Mobile Friendly Gravity Forms Google Font API Android Remote AI

Keywords

pharmaceutical manufacturing oncology innovation cancer treatment jylamvo methotrexate oral solution fda approved pediatric indications nelarabine injection acute lymphoblastic leukemia biopharmaceuticals drug development chemotherapy critical care quality assurance clinical trials patient care pain management autoimmune diseases drug formulation market access epidemiology vestibular technology clinical pharmacology therapeutic agents compassionate use orphan drugs milestones in oncology commercialization strategy research partnerships clinical oncology adverse reactions monitoring oncology pipeline patient accessibility clinical efficacy drug registration european medicines agency hematology regulatory affairs supply chain management pharmaceutical standards biological products medication adherence healthcare innovation community engagement patient advocacy collaborative research medical compliance specialty pharmaceuticals oncology drugs orphan cancers pediatric oncology innovative treatments drug shortages fda-approved products imkeldi oral liquid formulations women's cancers compassionate care patient-friendly dosing 505(b)(2) pathway healthcare providers underserved populations cancer care solutions biopharmaceutical development strategic expansion innovative oncology solutions re-formulation clinical problems patient adherence oncology market pharmaceutical industry cancer treatment innovation pharmaceuticals medical hospital & health care health care health wellness & fitness logistics & supply chain

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans